2026 Summer Intern – Global Medical Information at Acadia Pharmaceuticals

Parsippany, New Jersey, United States

Apply Now

Not SpecifiedCompensation

InternshipExperience Level

InternshipJob Type

UnknownVisa

Biopharmaceutical, PharmaceuticalIndustries

Requirements

In their 3rd year of pharmacy school or higher (finished with their 2nd year of Pharmacy school)
Experience in developing PowerPoint presentations
Experience with Microsoft Word
Good written and verbal communication skills
Team player skills/ability to work with others
For Parsippany-based roles: Expected to work no less than 4 days at the site in Parsippany, New Jersey, on days in conjunction with assigned team; may work 1 day per week remotely
Ability to complete the entire 10-week program (from May 26, 2026 to July 31, 2026) and commit to 37.5 hours per week
Cumulative 3.0 GPA or above; college transcript required (must mail official transcript by application deadline to specified address)
Currently enrolled in an accredited U.S. based college or university
Enrolled in either an undergraduate (Bachelor’s), graduate, MBA, JD, PharmD, or PhD program
Legally authorized to work in the U.S. without a need for sponsorship/CPT/OPT now or in the future
At least 18 years of age prior to the scheduled start date
Must be available to complete virtual interviews with HR and hiring manager
Must successfully pass a drug screen and background check prior to start date
Must complete a final presentation at the end of the 10-week program (mandatory)
Application deadline is January 9, 2026

Responsibilities

Updating Medical Information standard response letters, FAQ responses, and/or dossiers
Developing responses to escalated questions from the MI Call Center
Creating standard response letters and frequently asked question documents
Assisting with the monthly adverse event/product complaint reconciliation report
Working with the MI team on LMR reviews of promotional materials and field materials

Skills

Key technologies and capabilities for this role

Medical InformationPharmacyStandard Response LettersFAQ DevelopmentAdverse Event ReportingProduct Complaint ReconciliationLMR ReviewsPromotional Materials Review

Questions & Answers

Common questions about this position

What are the location and remote work expectations for this internship?

This role is based in Parsippany, New Jersey, and requires working no less than 4 days per week at the site, with the option to work 1 day per week remotely.

What are the required qualifications for this summer internship?

Candidates must be in their 3rd year of pharmacy school or higher, have experience developing PowerPoint presentations, experience with Microsoft Word, good written and verbal communication skills, and team player skills.

What is the duration and time commitment for the internship?

The internship runs for 10 weeks from May 26, 2026 to July 31, 2026, requiring a commitment of 37.5 hours per week.

What is the minimum GPA required for this intern position?

A cumulative GPA of 3.0 or above is required, and applicants must mail an official college transcript by the application deadline.

What does Ferring's company culture emphasize?

Ferring emphasizes a 'people first' philosophy, entrepreneurial spirit, long-term perspective, and commitment to science and research, and is certified as a Great Place to Work.

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters

1993Year Founded

$813.4MTotal Funding

ACQUISITIONCompany Stage

Biotechnology, HealthcareIndustries

501-1,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Paid Vacation

Paid Holidays

Paid Sick Leave

Paid Parental Leave

Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.

Potential clinical trial delays could affect drug approval timelines.

Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.

The company has a strong R&D foundation, developing innovative small molecule drugs.

Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.

Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.

The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI

Try Jobo Free